Home Healthcare Biotechnology Preterm Birth and PROM Testing Market

Preterm Birth and PROM Testing Market Size, Share & Trends Analysis Report By Test Type (Pelvic Examination, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Preterm Birth and PROM Testing Market Size & Growth Analysis

The global preterm birth and PROM testing market size was valued at USD 2.62 billion in 2025 and is projected to grow from USD 3.05 billion in 2026 to USD 10.22 billion by 2034, registering a CAGR of 16.33% during the forecast period from 2026 to 2034. North America dominated the preterm birth and PROM testing market with a market share of 38.2% in 2025.

Market Key Takeaways

Global Market Size & Growth

North America dominated the market and accounted for 40% of the USD 2.25 billion global market in 2024.
Europe accounted for nearly 30% of the global market in 2024, supported by high maternal health awareness and strong adoption of novel tests.
Asia-Pacific captured around 22% of the market in 2024 and is projected to grow at the fastest CAGR of 3.4% during the forecast period.
Based on test type, the ultrasound segment dominated the global preterm birth and PROM testing market in 2024, holding the largest share and projected to grow at a CAGR of 2.9%, driven by its reliability as a first-line, non-invasive imaging method for assessing cervical changes, amniotic fluid levels, and fetal health.
Preterm Birth and PROM Testing Market Size

Download a Free Sample To learn more about this report.

Market Segmentation

Test Type Insights

The market is bifurcated into Pelvic Examination, Ultrasound, Biochemical Markers, Uterine Monitoring, Nitazine Test, Ferning Test, Pooling, PAMG-1 Immunoassay, IGFBP Test, Fetal Fibronectin (fFN), and Others. The ultrasound segment dominates the global market share and is projected to exhibit a CAGR of 2.9% over the forecast period. One of the traditional techniques for determining preterm labour is ultrasound imaging. To evaluate if the cervix has dilated or effaced, doctors frequently do an ultrasound to get pictures of the uterus and the developing baby. To capture pictures of the pelvic area, transvaginal or endovaginal ultrasonography employs a transducer that produces sound waves painlessly. The transducer is greased before being placed into the vagina to record photos for viewing on a computer screen. One of the initial examinations a doctor or nurse performs is an ultrasound imaging test to determine the baby's weight, measure the amount of amniotic fluid present, and visually inspect the embryo's location. Key players are also making deliberate moves to broaden their product offerings.

  • For instance, Hologic and the Canadian business Clarius Mobile Health struck a development and distribution deal in November 2017. The portable ultrasound scanner from Clarius is one of the rights transferred under the deal. The goal of this program was to increase the company's ultrasound business.
Preterm Birth and PROM Testing Market Size By Segments

Request Customizationto receive a tailored report.

Preterm Birth and PROM Testing Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America Market Trend

North America is the most significant global preterm birth and prom testing market shareholder and is estimated to exhibit a CAGR of 3.5% over the forecast period. This is due to the high prevalence of pregnancies in the 35+ age group and the infrastructure's readiness to handle high-risk pregnancies. Premature births are on the rise in the United States due to changes in lifestyle variables such as excessive alcohol intake and sedentary behaviour. Several awareness campaigns and efforts by nonprofit organisations in the United States and Canada are addressing the difficulties experienced by preterm newborns and their families. For instance, to address the growing preterm birth rates and ongoing health disparities in the United States, the March of Dimes organised the Prematurity Campaign Collaborative in 2017.

North America Preterm Birth and PROM Testing Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Market Growth

Asia-Pacific is anticipated to exhibit a CAGR of 3.4% over the forecast period. The existence of a sizable population in China and India is the cause of this rise. Additionally, the growing rate of preterm births in the region's emerging nations is considered to expand a potential market in these nations and fuel the industry's rapid expansion. Rapid technical progress, the availability of a well-established healthcare system, a growth in awareness campaigns, and nonprofit organisations that help preterm newborns and their families are some of the key elements favourably influencing the market.

European Market Trends

Europe has emerged as one of the fastest-growing regions in the global market. High maternal health awareness and higher uptake of novel tests in nations like Germany, the U.K., Italy, and France are to blame for expanding the markets in Europe. The regional market is also anticipated to increase because of the presence of major companies locally and ongoing R&D projects in the fields of preterm births and PROM testing. The high frequency of alcohol misuse and cigarette use among pregnant women in the region is also anticipated to increase the risk of preterm deliveries and PROM, increasing the demand for testing solutions. The developed healthcare system and high rate of prenatal care adoption of cutting-edge preterm birth and PROM testing technologies may be credited for the market's success. Additionally, the nation's favourable reimbursement regulations for pricey testing solutions foster a good atmosphere for business expansion. The need for its testing solutions is also anticipated to increase due to the country's high risk of perinatal death and morbidity and significant prevalence of preterm births.

Latin America Market Trend

In Latin America, the market has huge room to develop. Due to the high occurrence of preterm births in Latin American nations, there may be a demand for preterm birth testing. These elements are projected to fuel market expansion in the area. An improved healthcare reimbursement structure has enhanced access to appropriate healthcare services for the region's underprivileged population. Growing consumer knowledge of numerous obstetric and prenatal care issues is another factor promoting market expansion in the area. Another element contributing to the market expansion in Latin America is rising healthcare spending. Brazil, Mexico, and Argentina are powerful nations that are categorised as being in Latin America.

In the Middle East and Africa, expanding the preterm birth and PROM testing industry may be ascribed to ongoing government efforts to provide regional access to cutting-edge preterm birth and PROM testing solutions. Additionally, there will be a large need for preterm birth and PROM testing solutions due to the rising risk of preterm birth and PROM caused by maternal malnutrition, infectious illnesses, bad living circumstances, and smoking in African nations. Uncertain reimbursement situations, a lacklustre healthcare system, and the high cost of pricey tests in several Middle East and African nations are anticipated to pose a serious challenge to the market's expansion.

List of Key and Emerging Players in Preterm Birth and PROM Testing Market

Qiagen N.V.
Hologic Inc.
Coopersurgical Inc.
Abbott
Medix Biochemica
Sera Prognostics
Clinical Innovations LLC
Biosynex
NX Prenatal
I.Q. Products

Key Industry Developments

May 2026
Hologic expanded its prenatal diagnostics portfolio with advanced testing solutions for identifying women at risk of preterm birth and premature rupture of membranes (PROM). The new assays improve diagnostic accuracy and support timely clinical intervention. They strengthen the company's women's health diagnostics business.
April 2026
QIAGEN introduced upgraded molecular testing solutions for maternal and fetal health applications. The enhancements provide faster and more reliable results for pregnancy-related diagnostic testing. They reinforce the company's prenatal diagnostics portfolio.
February 2026
Abbott expanded its maternal health diagnostics portfolio with improved laboratory testing solutions for pregnancy complications. The new technologies support earlier risk assessment and better clinical decision-making. They strengthen the company's women's health offerings.
October 2025
Sera Prognostics advanced the commercialization of its biomarker-based pregnancy risk assessment platform. The technology helps identify women at increased risk of spontaneous preterm birth. It reinforces the company's leadership in maternal health diagnostics.

Report Scope

Segmentation

By Test Type 10
  • Pelvic Examination
  • Ultrasound
  • Biochemical Markers
  • Uterine Monitoring
  • Nitazine Test, Ferning Test
  • Pooling
  • PAMG-1 Immunoassay
  • IGFBP Test
  • Fetal Fibronectin (fFN)
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 8
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Singapore
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Qiagen N.V. · Hologic Inc. · Coopersurgical Inc. · Abbott · Medix Biochemica
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The preterm birth and prom testing market size is valued at USD 3.05 Billion in 2026 and is projected to reach USD 10.22 Billion by 2034, at a CAGR of 16.33% during the forecast period 2026-2034.
North America dominated the market with a share of 38.2% in 2025.
The leading players in this market are Qiagen N.V., Hologic Inc., Coopersurgical Inc., Abbott, Medix Biochemica.
The preterm birth and prom testing market is projected to grow at a CAGR of 16.33% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now